Renalytix Statistics
Total Valuation
Renalytix has a market cap or net worth of $39.55 million. The enterprise value is $44.26 million.
Market Cap | 39.55M |
Enterprise Value | 44.26M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, before market open.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Renalytix has 77.18 million shares outstanding.
Shares Outstanding | 77.18M |
Owned by Insiders (%) | 4.85% |
Owned by Institutions (%) | 5.53% |
Float | 64.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 17.81 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 19.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42
Current Ratio | 0.42 |
Quick Ratio | 0.35 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -213.60% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $21,775 |
Profits Per Employee | -$367,510 |
Employee Count | 102 |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Renalytix has paid $8,000 in taxes.
Income Tax | 8,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.27% in the last 52 weeks. The beta is 1.98, so Renalytix's price volatility has been higher than the market average.
Beta (1Y) | 1.98 |
52-Week Price Change | -75.27% |
50-Day Moving Average | 0.80 |
200-Day Moving Average | 1.10 |
Relative Strength Index (RSI) | 33.62 |
Average Volume (30 Days) | 841,058 |
Short Selling Information
Short Interest | 627,397 |
Short Previous Month | 673,716 |
Short % of Shares Out | 1.52% |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.78 |
Income Statement
In the last 12 months, Renalytix had revenue of $2.22 million and -$37.49 million in losses. Loss per share was -$0.78.
Revenue | 2.22M |
Gross Profit | -35,000 |
Operating Income | -34.02M |
Pretax Income | -37.48M |
Net Income | -37.49M |
EBITDA | -36.96M |
EBIT | -37.48M |
Loss Per Share | -$0.78 |
Balance Sheet
The company has $4.70 million in cash and $9.42 million in debt, giving a net cash position of -$4.72 million or -$0.06 per share.
Cash & Cash Equivalents | 4.70M |
Total Debt | 9.42M |
Net Cash | -4.72M |
Net Cash Per Share | -$0.06 |
Equity / Book Value | -11.11M |
Book Value Per Share | -0.14 |
Working Capital | -8.65M |
Cash Flow
In the last 12 months, operating cash flow was -$30.92 million and capital expenditures -$3,000, giving a free cash flow of -$30.92 million.
Operating Cash Flow | -30.92M |
Capital Expenditures | -3,000 |
Free Cash Flow | -30.92M |
FCF Per Share | -$0.63 |
Margins
Gross margin is -1.58%, with operating and profit margins of -1,531.61% and -1,687.80%.
Gross Margin | -1.58% |
Operating Margin | -1,531.61% |
Pretax Margin | -1,687.44% |
Profit Margin | -1,687.80% |
EBITDA Margin | -1,664.07% |
EBIT Margin | -1,687.44% |
FCF Margin | -1,392.21% |
Dividends & Yields
Renalytix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.14% |
Shareholder Yield | -14.14% |
Earnings Yield | -94.78% |
FCF Yield | -78.18% |
Analyst Forecast
The average price target for Renalytix is $5.00, which is 874.47% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.00 |
Price Target Difference | 874.47% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Renalytix has an Altman Z-Score of -46.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -46.52 |
Piotroski F-Score | 3 |